» Articles » PMID: 38646215

A Case of Palmoplantar Keratoderma in the Constellation of Connective Tissue Diseases

Overview
Journal Cureus
Date 2024 Apr 22
PMID 38646215
Authors
Affiliations
Soon will be listed here.
Abstract

Overlap syndrome is a clinical challenge and brings together a wide range of treatment options for the treating physician. Addressing each and every complaint of the patient is crucial. A 50-year-old female patient presented with skin thickening, blackening, and hyperkeratosis; dysphagia; joint pain; features of myopathy; Raynaud's phenomenon; and dry mouth. Inflammatory markers were raised along with a positive antinuclear antibody (ANA) with Golgi apparatus pattern, anti-Sjögren's-syndrome-related antigen A (anti-SSA)/Ro60 3+, anti-SSA/Ro52 3+, and anti-PM/Scl 2+ antibodies that suggested overlap syndrome. Although the patient had no respiratory complaints, a unique interstitial lung disease (ILD) pattern was noted during the evaluation. Skin manifestations were puzzling, but the histopathology analyses of skin biopsies taken from two different sites revealed distinguishing features of cutaneous lupus and dermatomyositis. Treatment with hydroxychloroquine, pilocarpine, nifedipine, methotrexate, and topical tacrolimus produced a dramatic improvement in the clinical features. This case highlights subtle and florid features of different autoimmune diseases. The hyperkeratotic skin changes were the most striking feature, but the whole evaluation process unveiled many rare presentations of known autoimmune conditions that can open doors to new areas of our understanding toward connective tissue diseases (CTDs). Our case report demonstrates significant heterogeneity in the ANA patterns, ILD patterns, clinical manifestations, and treatment approaches.

References
1.
Morrell T, Mortensen W, Langley S . Amyopathic dermatomyositis with plantar keratoderma responding to methotrexate therapy. Cutis. 2017; 100(2):E20-E24. View

2.
Fudman E, Schnitzer T . Dermatomyositis without creatine kinase elevation. A poor prognostic sign. Am J Med. 1986; 80(2):329-32. DOI: 10.1016/0002-9343(86)90036-7. View

3.
Ge Y, Shu X, He L, Li C, Lu X, Wang G . Interstitial Lung Disease Is a Major Characteristic of Patients Who Test Positive for Anti-PM/Scl Antibody. Front Med (Lausanne). 2022; 8:778211. PMC: 8804089. DOI: 10.3389/fmed.2021.778211. View

4.
Bergeret B, Secco L, Pallure V, Daien C, Pers Y, Gottlieb J . Palmoplantar lichen planus-like lupus erythematosus keratoderma: an underrecognized and distinctive cutaneous manifestation of systemic or subacute lupus erythematosus. J Eur Acad Dermatol Venereol. 2020; 35(2):e124-e126. DOI: 10.1111/jdv.16852. View

5.
Patra P, Banday A, Bansal R, Sudhakar M, Jindal A . Palmoplantar keratoderma as the preceding cutaneous manifestation of juvenile-onset dermatomyositis. Eur J Rheumatol. 2020; 8(4):237-238. PMC: 10176234. DOI: 10.5152/eurjrheum.2020.20068. View